|
26 Companies |
|
28 Products |
|
28 Products |
|
26 Mechanisms of Action |
|
1 Trial |
|
237 News |
|
| «12345» |
- || Trial primary completion date: Stress Hormones, Mood and Women's Sexual Desire (MODEST) (clinicaltrials.gov) - Jun 15, 2015
P=N/A, N=320, Recruiting, Sponsor: University of British Columbia
Trial primary completion date: Nov 2015 --> Nov 2016
- Enrollment change, Trial withdrawal: Stem Cells for the Improvement of Erectile and Cardiac Function in Aging Men (clinicaltrials.gov) - Jun 11, 2015
P1, N=0, Withdrawn, Sponsor: Baylor College of Medicine
Trial primary completion date: Nov 2015 --> Nov 2016 N=45 --> 0 | Not yet recruiting --> Withdrawn
- ||| Trial completion: Low Intensity Extracorporeal Shockwave Therapy (LI-ESWT) by 'Renova' for Patients With Erectile Dysfunction (clinicaltrials.gov) - May 12, 2015
P=N/A, N=60, Completed, Sponsor: Initia
N=45 --> 0 | Not yet recruiting --> Withdrawn Active, not recruiting --> Completed
- || Trial primary completion date: PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) (clinicaltrials.gov) - May 5, 2015
P4, N=284, Recruiting, Sponsor: Bayer
Active, not recruiting --> Completed Trial primary completion date: Feb 2016 --> Dec 2017
- Trial primary completion date: Outcomes of Delivery in Patients With Dyspareunia (clinicaltrials.gov) - Apr 21, 2015
P=N/A, N=200, Recruiting, Sponsor: Hadassah Medical Organization
Trial primary completion date: Feb 2016 --> Dec 2017 Trial primary completion date: Feb 2015 --> Dec 2015
- fluocinonide / Generic mfg.
Trial primary completion date: Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy (clinicaltrials.gov) - Apr 19, 2015
P2, N=35, Recruiting, Sponsor: OHSU Knight Cancer Institute
Trial primary completion date: Feb 2015 --> Dec 2015 Trial primary completion date: Mar 2015 --> Jul 2015
- Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
Trial completion, Enrollment change, Trial primary completion date: VginsmsBOTOX: Injection of Botox in the Perineal Muscles in Resistant Cases of Vaginal Spasm (clinicaltrials.gov) - Apr 14, 2015
P=N/A, N=32, Completed, Sponsor: Abdel-Maguid Ramzy
Trial primary completion date: Mar 2015 --> Jul 2015 Recruiting --> Completed | N=20 --> 32 | Trial primary completion date: Dec 2013 --> Mar 2014
- Trial completion, Trial primary completion date, Surgery: Dilators for Dyspareunia Prevention (clinicaltrials.gov) - Apr 9, 2015
P4, N=60, Completed, Sponsor: Medstar Research Institute
Recruiting --> Completed | N=20 --> 32 | Trial primary completion date: Dec 2013 --> Mar 2014 Active, not recruiting --> Completed | Trial primary completion date: Sep 2012 --> Aug 2013
- Trial completion, Trial primary completion date: Postpartum Dyspareunia Resulting From Vaginal Atrophy (clinicaltrials.gov) - Apr 8, 2015
P=N/A, N=117, Completed, Sponsor: Meir Medical Center
Active, not recruiting --> Completed | Trial primary completion date: Sep 2012 --> Aug 2013 Recruiting --> Completed | Trial primary completion date: Mar 2013 --> Sep 2013
- Trial completion, Trial primary completion date: Effects of Tribulus Terrestris in Postmenopausal Women With Hypoactive Sexual Desire Disorder (clinicaltrials.gov) - Apr 3, 2015
P4, N=44, Completed, Sponsor: Federal University of Minas Gerais
Recruiting --> Completed | Trial primary completion date: Mar 2013 --> Sep 2013 Recruiting --> Completed | Trial primary completion date: Aug 2015 --> Apr 2015
- |||| Trial completion: Lybridos in Pre-and Postmenopausal Women With Hypoactive Sexual Desire Disorder (clinicaltrials.gov) - Mar 24, 2015
P2, N=80, Completed, Sponsor: Emotional Brain NY Inc.
Recruiting --> Completed | Trial primary completion date: Aug 2015 --> Apr 2015 Active, not recruiting --> Completed
- ||||||| tadalafil / Generic mfg.
Trial completion: Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy (clinicaltrials.gov) - Mar 18, 2015
P3, N=242, Completed, Sponsor: Radiation Therapy Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Effect of Functional Electrical Stimulation on Erectile Dysfunction (clinicaltrials.gov) - Mar 7, 2015
P=N/A, N=22, Completed, Sponsor: Federal University of Health Science of Porto Alegre
Active, not recruiting --> Completed Not yet recruiting --> Completed
- Trial completion, Trial primary completion date: Prevalence and Risk Factors of Erectile Dysfunction in Type 2 Diabetic Patients (clinicaltrials.gov) - Mar 3, 2015
P=N/A, N=220, Completed, Sponsor: University of Pavia
Not yet recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Dec 2013 --> Jul 2014
- |||| tadalafil / Generic mfg.
Trial primary completion date: A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED) (clinicaltrials.gov) - Feb 19, 2015
P3, N=890, Recruiting, Sponsor: Eli Lilly and Company
Active, not recruiting --> Completed | Trial primary completion date: Dec 2013 --> Jul 2014 Trial primary completion date: Mar 2016 --> Dec 2015
- Trial initiation date, Trial primary completion date: Stem Cells for the Improvement of Erectile and Cardiac Function in Aging Men (clinicaltrials.gov) - Feb 5, 2015
P1, N=45, Not yet recruiting, Sponsor: Baylor College of Medicine
Trial primary completion date: Mar 2016 --> Dec 2015 Initiation date: Jun 2014 --> May 2015 | Trial primary completion date: Mar 2019 --> Mar 2020
- |||| Stendra (avanafil) / IEH Biopharma, Menarini, Endo
Trial completion, Trial primary completion date: Study Evaluating the Effects of Avanafil on Semen Parameters (clinicaltrials.gov) - Jan 30, 2015
P4, N=181, Completed, Sponsor: VIVUS, Inc.
Initiation date: Jun 2014 --> May 2015 | Trial primary completion date: Mar 2019 --> Mar 2020 Active, not recruiting --> Completed | Trial primary completion date: Feb 2014 --> Aug 2014
- Cellgram-ED (autologous mesenchymal stem cell therapy) / Pharmicell
New P1 trial: Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Erectile Dysfunction (clinicaltrials.gov) - Jan 26, 2015
P1, N=10, Not yet recruiting, Sponsor: Pharmicell Co., Ltd.
- fluocinonide / Generic mfg.
Trial primary completion date: Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy (clinicaltrials.gov) - Jan 2, 2015
P2, N=35, Recruiting, Sponsor: OHSU Knight Cancer Institute
Active, not recruiting --> Completed | Trial primary completion date: Feb 2014 --> Aug 2014 Trial primary completion date: Nov 2014 --> Mar 2015
- ||||| vardenafil / Generic mfg.
Enrollment change, HEOR: Assess Efficacy of Vardenafil 10mg in Erectile Dysfunction Within Intake of 6 Hours (clinicaltrials.gov) - Dec 24, 2014
P3, N=887, Completed, Sponsor: Bayer
Trial primary completion date: Nov 2014 --> Mar 2015 N=1200 --> 887
- || vardenafil / Generic mfg.
Trial primary completion date: LEVITRA (clinicaltrials.gov) - Dec 17, 2014
P=N/A, N=1221, Completed, Sponsor: Bayer
N=1200 --> 887 Trial primary completion date: Dec 2009 --> Mar 2010
- ||||| vardenafil / Generic mfg.
Enrollment change: BAY38-9456 (Vardenafil HCL Tablet) in ED Treatment for China Registration. (clinicaltrials.gov) - Dec 17, 2014
P3, N=624, Completed, Sponsor: Bayer
Trial primary completion date: Dec 2009 --> Mar 2010 N=480 --> 624
- Trial completion, Trial initiation date: ECSIITED: Exploratory CSII Trial on Erectile Dysfunction in T2DM Patients (clinicaltrials.gov) - Dec 12, 2014
P4, N=20, Completed, Sponsor: Jothydev's Diabetes and Research Centre
N=480 --> 624 Recruiting --> Completed | Initiation date: Jan 2011 --> Jan 2012
- ||| vardenafil / Generic mfg.
Enrollment change: Evaluation of LEVITRA to Advance the Treatment of Erectile Dysfunction (clinicaltrials.gov) - Dec 10, 2014
P4, N=1029, Completed, Sponsor: Bayer
Recruiting --> Completed | Initiation date: Jan 2011 --> Jan 2012 N=1380 --> 1029
- Enrollment closed, Trial primary completion date, Surgery: A Couple Support Intervention for Prostate Cancer (clinicaltrials.gov) - Dec 7, 2014
P1, N=136, Active, not recruiting, Sponsor: University of Stirling
N=1380 --> 1029 Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2014 --> Feb 2015
- Trial primary completion date, MRI: MRI Temperature Mapping of the Prostate and Urogenital Pelvis Cooled by an Endorectal Balloon (clinicaltrials.gov) - Dec 6, 2014
P=N/A, N=40, Recruiting, Sponsor: University of California, Irvine
Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2014 --> Feb 2015 Trial primary completion date: Aug 2014 --> Aug 2016
- ||||| vardenafil / Generic mfg.
Enrollment change: Study Evaluating the Efficacy, Safety, and Reliability of Vardenafil (clinicaltrials.gov) - Dec 6, 2014
P3, N=523, Completed, Sponsor: Bayer
Trial primary completion date: Aug 2014 --> Aug 2016 N=739 --> 523
- || Enrollment closed, Trial primary completion date: ESWTvsED: Low-energy Linear Extracorporal Shock Wave Therapy for Erectile Dysfunction. (clinicaltrials.gov) - Dec 6, 2014
P=N/A, N=126, Active, not recruiting, Sponsor: Grzegorz Fojecki
N=739 --> 523 Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2015 --> Aug 2014
- ||||| vardenafil / Generic mfg.
Enrollment change: Study Evaluating the Efficacy and Safety of Flexible-dose Vardenafil in Subjects With Erectile Dysfunction (clinicaltrials.gov) - Dec 5, 2014
P3, N=463, Completed, Sponsor: Bayer
Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2015 --> Aug 2014 N=761 --> 463
- Trial completion, Enrollment change: Effects of Early Abuse on Adult Intimate Relationships (clinicaltrials.gov) - Dec 5, 2014
P=N/A, N=148, Completed, Sponsor: University of Texas at Austin
N=761 --> 463 Active, not recruiting --> Completed | N=300 --> 148
- Trial completion, Enrollment change: SHAPE: Sexual Health on Antidepressants Through Physical Exercise (clinicaltrials.gov) - Dec 5, 2014
P=N/A, N=52, Completed, Sponsor: University of Texas at Austin
Active, not recruiting --> Completed | N=300 --> 148 Active, not recruiting --> Completed | N=75 --> 52
- Clinical: A New Treatment for Premature Ejaculation? (clinicaltrials.gov) - Nov 23, 2014
P=N/A, N=10, Completed, Sponsor: Instituto Sexológico Murciano
- || Trial primary completion date: PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) (clinicaltrials.gov) - Oct 31, 2014
P4, N=284, Recruiting, Sponsor: Bayer
Active, not recruiting --> Completed | N=75 --> 52 Trial primary completion date: Feb 2015 --> Feb 2016
- | trazodone ER / Generic mfg., bupropion / Generic mfg.
Trial completion, Trial primary completion date: Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety (clinicaltrials.gov) - Oct 28, 2014
P1/2, N=30, Completed, Sponsor: S1 Biopharma, Inc.
Trial primary completion date: Feb 2015 --> Feb 2016 Recruiting --> Completed | Trial primary completion date: Sep 2013 --> Oct 2014
- Trial completion, Trial primary completion date: TERMSINFAT: Testosterone Replacement in Metabolic Syndrome and Inflammation (clinicaltrials.gov) - Oct 28, 2014
P4, N=82, Completed, Sponsor: University of Roma La Sapienza
Recruiting --> Completed | Trial primary completion date: Sep 2013 --> Oct 2014 Recruiting --> Completed | Trial primary completion date: Aug 2013 --> Oct 2014
- Trial completion, Enrollment change: Acupuncture for Sexual Dysfunction (clinicaltrials.gov) - Oct 17, 2014
P=N/A, N=15, Completed, Sponsor: TriHealth Inc.
Recruiting --> Completed | Trial primary completion date: Aug 2013 --> Oct 2014 Recruiting --> Completed | N=20 --> 15
- |||||||||| New P3 trial: Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women (clinicaltrials.gov) - Oct 2, 2014
P3, N=700, Recruiting, Sponsor: TherapeuticsMD
- Enrollment open, Trial primary completion date: Outcomes of Delivery in Patients With Dyspareunia (clinicaltrials.gov) - Sep 30, 2014
P=N/A, N=200, Recruiting, Sponsor: Hadassah Medical Organization
Recruiting --> Completed | N=20 --> 15 Not yet recruiting --> Recruiting | Trial primary completion date: Feb 2014 --> Feb 2015
- || Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
Trial primary completion date: A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation (clinicaltrials.gov) - Sep 22, 2014
P2, N=60, Recruiting, Sponsor: Allergan
Not yet recruiting --> Recruiting | Trial primary completion date: Feb 2014 --> Feb 2015 Trial primary completion date: Jul 2015 --> Jan 2016
- |||| Tefina (testosterone intranasal) / Acerus
Trial completion, Trial primary completion date: Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder (clinicaltrials.gov) - Sep 19, 2014
P2, N=253, Completed, Sponsor: Trimel Biopharma SRL
Trial primary completion date: Jul 2015 --> Jan 2016 Recruiting --> Completed | Trial primary completion date: Dec 2013 --> May 2014
- | tamsulosin / Generic mfg.
New P1 trial: Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin (clinicaltrials.gov) - Sep 12, 2014
P1, N=30, Completed, Sponsor: Hanmi Pharmaceutical Company Limited
- Trial completion, Trial primary completion date: EPIPARA: Descriptive Epidemiology Study for Patients With Paraphilia Sex Offenders and Receiving Androgen Antagonists (clinicaltrials.gov) - Sep 8, 2014
P=N/A, N=213, Completed, Sponsor: University Hospital, Rouen
Recruiting --> Completed | Trial primary completion date: Dec 2013 --> May 2014 Recruiting --> Completed | Trial primary completion date: Dec 2013 --> Jun 2014
- Clinical: Effectiveness of Physiotherapy to Treat the Urinary Incontinence and Erectile Dysfunction Post Retropubic Prostatectomy (clinicaltrials.gov) - Aug 27, 2014
P=N/A, N=150, Active, not recruiting, Sponsor: Barretos Cancer Hospital
- | vardenafil / Generic mfg.
New P2 trial: DiVa: Diabetes & Vardenafil (clinicaltrials.gov) - Aug 19, 2014
P2, N=54, Completed, Sponsor: Azienda USL Modena
- |||| tadalafil / Generic mfg.
Trial completion: Safety and Efficacy of YHD1023 in Erectile Dysfunction (clinicaltrials.gov) - Aug 1, 2014
P2, N=104, Completed, Sponsor: Yuhan Corporation
Recruiting --> Completed | Trial primary completion date: Dec 2013 --> Jun 2014 Active, not recruiting --> Completed
- | Addyi (flibanserin) / Sprout Pharma
Trial termination: A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD). (clinicaltrials.gov) - Jun 13, 2014
P3, N=1723, Terminated, Sponsor: Sprout Pharmaceuticals, Inc
Active, not recruiting --> Completed Completed --> Terminated; terminated for administrative reasons
- Trial suspension: Safety and Efficacy Associated With Treating Erectile Dysfunction Patients With Low Intensity Shockwaves by Renova (clinicaltrials.gov) - Jun 12, 2014
P=N/A, N=40, Suspended, Sponsor: Initia
Completed --> Terminated; terminated for administrative reasons Recruiting --> Suspended
- Trial primary completion date: ECSIITED: Exploratory CSII Trial on Erectile Dysfunction in T2DM Patients (clinicaltrials.gov) - May 28, 2014
P4, N=20, Recruiting, Sponsor: Jothydev's Diabetes and Research Centre
Recruiting --> Suspended Trial primary completion date: Aug 2014 --> Nov 2014
- Trial completion date: ECSIITED: Exploratory CSII Trial on Erectile Dysfunction in T2DM Patients (clinicaltrials.gov) - May 28, 2014
P4, N=20, Recruiting, Sponsor: Jothydev's Diabetes and Research Centre
Trial primary completion date: Aug 2014 --> Nov 2014 Trial completion date: Aug 2014 --> Dec 2014
- | sildenafil / Generic mfg.
Trial completion: Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer (clinicaltrials.gov) - Apr 22, 2014
P3, N=290, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Trial completion date: Aug 2014 --> Dec 2014 Active, not recruiting --> Completed